Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Significant Shareholder

19 Feb 2007 16:03

Reconstruction Capital II Ltd19 February 2007 Reconstruction Capital II Limited (the "Company") 19th February 2006 Significant Shareholding The Company was notified on 19th February 2006 that Nortrust Nominees has sold50,000 ordinary shares in the Company. As such, Nortrust Nominees now has anotifiable interest of 3,250,000 ordinary shares (4.99%) in the issued ordinaryshare capital of the Company. For more information: Reconstruction Capital II LimitedIon FlorescuTel: +44 7767 477192 Grant Thornton Corporate Finance (Nominated Adviser)Philip SecrettTel: +44 870 991 2578 LCF Edmund de Rothschild (Broker)Claire HeathfieldTel: +44 20 7845 5960 This information is provided by RNS The company news service from the London Stock Exchange

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.